NFKB1 and neoplasm: In this regard, therapeutically disabling NF-κB p65 (RelA) expression and enzyme functioning seems like a better approach to disrupting the NF-κB p65 (RelA) inflammatory signaling cascade by preventing the spread and invasion of tumor cells.